Tsung-I Hsu

national taiwan university of science & technology

H指数:32

被引数:3,108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Dual CYP17A1/HDAC6 Inhibitor for Targeted Prostate Cancer Therapy

一种双CYP17A1/HDAC6抑制剂，用于靶向性前列腺癌治疗

The FASEB Journal

IF0

2025-10-170

PRE

Earthquake detection system strategy based on multi-hop wireless sensor network using MEMS sensor

基于多跳无线传感器网络和MEMS传感器的地震检测系统策略

JOURNAL OF INSTRUMENTATION

IF1.3

2025-10-010

PRE

Calanquinone A suppresses glioma progression via STAT3-mediated regulation of c-Myc and MMP9

Calanquinone A 通过 STAT3 介导的 c-Myc 和 MMP9 调控抑制胶质瘤进展。

Discover Oncology

IF2.9

2025-08-040

Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies

利奈唑胺再利用与组蛋白去乙酰化酶抑制剂联用，在胶质母细胞瘤治疗领域中的应用

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-01-210

ROLE OF PGE2-REGULATED NEUROINFLAMMATION IN CONSTRUCTING NEURON-NK-GLIOMA CIRCUIT FOR GLIOBLASTOMA

NEURO-ONCOLOGY

IF13.4

2024-11-110

PRE

Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-08-061

OAAI

Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma

负载多西他赛的介孔二氧化硅纳米颗粒克服血脑肿瘤屏障，用于治疗替莫唑胺耐药的胶质母细胞瘤

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-04-176

OAAI

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

CANCER LETTERS

IF10.1

2024-04-013

PRE

Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma

Mitochondrion

IF4.5

2024-03-017

PRE

First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-01-293

OAAI

Neurocutaneous Melanosis with Meningeal Melanocytosis: A Rare Case of Intracranial Hypertension and Cutaneous Manifestations

LIFE-BASEL

IF3.4

2024-01-180

OAAI

The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2023-09-012

PRE

Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities

LIPIDS IN HEALTH AND DISEASE

IF4.2

2023-08-0311

OAAI

Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-08-018

OAAI

Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-07-142

OAAI

Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2022-03-2529

OAAI

Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma

NEUROTHERAPEUTICS

IF6.9

2022-03-0116

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-02-0216

OAAI

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells

CELL DEATH & DISEASE

IF9.6

2021-09-2817

OAAI

17β-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2021-08-0115

PREAI

Tsung-I Hsu

个人简介

教育背景

工作经历

荣誉奖项

研究方向